The Finnish Funding Agency for Innovation has agreed to a three-year extension of the due date for Nexstim's research and development project loan repayments. The company is now required to pay up to approximately $2 million for two of its project loans between 2020 and 2022, later than the formerly agreed-upon period of 2017 to 2019, with full repayment of both loans expected by the end of 2023.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.